Home/Filings/4/0001615219-21-000095
4//SEC Filing

Rosenblum Mark J 4

Accession 0001615219-21-000095

CIK 0001615219other

Filed

Nov 4, 8:00 PM ET

Accepted

Nov 5, 2:54 PM ET

Size

4.9 KB

Accession

0001615219-21-000095

Insider Transaction Report

Form 4
Period: 2021-11-03
Rosenblum Mark J
Exec VP Finance, CFO
Transactions
  • Award

    Common Stock

    2021-11-03$0.72/sh+7,787$5,59134,073 total
Footnotes (1)
  • [F1]The reporting person voluntarily agreed to receive a percentage of his base salary in issuer shares and receive these shares in lieu of net cash compensation. Shares are purchased at a price determined pursuant to the issuer's Employee Stock Purchase Plan.

Issuer

Salarius Pharmaceuticals, Inc.

CIK 0001615219

Entity typeother

Related Parties

1
  • filerCIK 0001329154

Filing Metadata

Form type
4
Filed
Nov 4, 8:00 PM ET
Accepted
Nov 5, 2:54 PM ET
Size
4.9 KB